Rapid Re-expression of Retrovirally Introduced VersusEndogenous TCRs in Engineered T cells AfterAntigen-specific Stimulation

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of immunotherapy

• Publication date

  2011-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1097/CJI.0b013e318206a10cPMID 21304404
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen.

  2009cited by this paper
• Kinetic preservation of dual specificity of coprogrammed minor histocompatibility antigen-reactive virus-specific T cells.

  2009cited by this paper
• Lack of specific gamma-retroviral vector long terminal repeat promoter silencing in patients receiving genetically engineered lymphocytes and activation upon lymphocyte restimulation.

  2009cited by this paper
• Virus-specific T cells engineered to coexpress tumor-specific receptors: persistence and antitumor activity in individuals with neuroblastoma

  2008cited by this paper
• Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes.

  2008cited by this paper
• Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes

  2006cited by this paper
• Alphabeta T-cell receptor engineered gammadelta T cells mediate effective antileukemic reactivity.

  2006cited by this paper
• Elimination of human leukemia cells in NOD/SCID mice by WT1-TCR gene-transduced human T cells.

  2005cited by this paper
• Transient Loss of MHC Class I Tetramer Binding after CD8+ T Cell Activation Reflects Altered T Cell Effector Function1

  2005cited by this paper
• Distinct role of lymphocyte function-associated antigen-1 in mediating effective cytolytic activity by cytotoxic T lymphocytes.

  2005cited by this paper
• Enhanced Transgene Expression in Quiescent and Activated Human CD8+ T Cells

  2004cited by this paper
• Reprogramming of Virus-specific T Cells into Leukemia-reactive T Cells Using T Cell Receptor Gene Transfer

  2004cited by this paper
• Molecular mechanisms for the assembly of the T cell receptor-CD3 complex.

  2004cited by this paper
• Redirection of antileukemic reactivity of peripheral T lymphocytes using gene transfer of minor histocompatibility antigen HA-2-specific T-cell receptor complexes expressing a conserved alpha joining region.

  2003cited by this paper
• TCR Comodulation of Nonengaged TCR Takes Place by a Protein Kinase C and CD3γ Di-Leucine-Based Motif-Dependent Mechanism 1

  2003cited by this paper
• The Immunological Synapse Balances T Cell Receptor Signaling and Degradation

  2003cited by this paper
• Surface T‐cell antigen receptor expression and availability for long‐term antigenic signaling

  2003cited by this paper
• A reversible functional defect of CD8+ T lymphocytes involving loss of tetramer labeling

  2002cited by this paper
• c-Cbl and Cbl-b regulate T cell responsiveness by promoting ligand-induced TCR down-modulation

  2002cited by this paper
• T-cell-receptor gene therapy

  2002cited by this paper
• Circumventing tolerance to a human MDM2-derived tumor antigen by TCR gene transfer

  2001cited by this paper
• Immunotherapy through TCR gene transfer

  2001cited by this paper
• Triggering the TCR complex causes the downregulation of nonengaged receptors by a signal transduction-dependent mechanism.

  2000cited by this paper
• Peptide-MHC Class I Tetrameric Complexes Display Exquisite Ligand Specificity1

  2000cited by this paper
• Transfer of Specificity for Human Immunodeficiency Virus Type 1 into Primary Human T Lymphocytes by Introduction of T-Cell Receptor Genes

  2000cited by this paper
• Dissection of the Role of CD3γ Chains in Profound but Reversible T‐Cell Receptor Down‐regulation

  2000cited by this paper
• Coordinate Regulation of T Cell Activation by CD2 and CD281

  2000cited by this paper
• T Cell Receptor (TCR) Antagonism without a Negative Signal: Evidence from T Cell Hybridomas Expressing Two Independent TCRs

  1999cited by this paper
• TCRζ is transported to and retained in the Golgi apparatus independently of other TCR chains: implications for TCR assembly

  1999cited by this paper
• Efficient transfer of a tumor antigen-reactive TCR to human peripheral blood lymphocytes confers anti-tumor reactivity.

  1999cited by this paper
• Expression of the T cell antigen receptor zeta chain following activation is controlled at distinct checkpoints. Implications for cell surface receptor down-modulation and re-expression.

  1999cited by this paper
• Costimulation of Transduced T Lymphocytes via T Cell Receptor-CD3 Complex and CD28 Leads to Increased Transcription of Integrated Retrovirus

  1999cited by this paper
• Activation of retrovirally transduced T lymphocytes.

  1998cited by this paper
• Activation of Retrovirally Transduced T Lymphocytes

  1998cited by this paper
• Peptide antigen or superantigen-induced down-regulation of TCRs involves both stimulated and unstimulated receptors.

  1997cited by this paper
• The alpha chain of the T cell antigen receptor is degraded in the cytosol.

  1997cited by this paper
• Degradation of  T Cell Receptor (TCR)–CD3-ζ Complexes after Antigenic Stimulation

  1997cited by this paper
• A dominant-negative mutant of the Rab5 GTPase enhances T cell signaling by interfering with TCR down-modulation in transgenic mice.

  1997cited by this paper
• Inhibition of T Cell and Promotion of Natural Killer Cell Development by the Dominant Negative Helix Loop Helix Factor Id3

  1997cited by this paper
• Activation of the Lck tyrosine kinase targets cell surface T cell antigen receptors for lysosomal degradation.

  1997cited by this paper
• Cell-Surface Marking of CD34+-Restricted Phenotypes of Human Hematopoietic Progenitor Cells by Retrovirus-Mediated Gene Transfer

  1997cited by this paper
• High transdominant RevM10 protein levels are required to inhibit HIV-1 replication in cell lines and primary T cells: implication for gene therapy of AIDS

  1997cited by this paper
• Episomal Vectors Rapidly and Stably Produce High-Titer Recombinant Retrovirus

  1996cited by this paper
• Evidence that a single peptide-MHC complex on a target cell can elicit a cytolytic T cell response.

  1996cited by this paper
• T Cell Activation Determined by T Cell Receptor Number and Tunable Thresholds

  1996cited by this paper
• Evidence for multivalent structure of T-cell antigen receptor complex.

  1995cited by this paper
• Serial triggering of many T-cell receptors by a few peptide–MHC complexes

  1995cited by this paper
• Minimal requirements for peptide mediated activation of CD8+ CTL.

  1994cited by this paper
• Correlation between up-regulation of lymphokine mRNA and down-regulation of TcR, CD4, CD8 and lck mRNA as shown by the effect of CsA on activated T lymphocytes.

  1992cited by this paper
• Down-regulation of T cell receptors on self-reactive T cells as a novel mechanism for extrathymic tolerance induction.

  1991cited by this paper
• The gamma and epsilon subunits of the CD3 complex inhibit pre-Golgi degradation of newly synthesized T cell antigen receptors

  1990cited by this paper
• Quantitation of antigen-presenting cell MHC class II/peptide complexes necessary for T-cell stimulation

  1990cited by this paper
• The minimal number of class II MHC-antigen complexes needed for T cell activation.

  1990cited by this paper
• Role of the zeta chain in the expression of the T cell antigen receptor: genetic reconstitution studies.

  1989cited by this paper
• Pre-Golgi degradation of newly synthesized T-cell antigen receptor chains: intrinsic sensitivity and the role of subunit assembly

  1989cited by this paper
• The T cell receptor/CD3 complex: a dynamic protein ensemble.

  1988cited by this paper
• Independent association of T cell receptor beta and gamma chains with CD3 in the same cell

  1987cited by this paper
• Transfer of specificity by murine alpha and beta T-cell receptor genes.

  1986cited by this paper
• Two antigen-independent adhesion pathways used by human cytotoxic T-cell clones

  1986cited by this paper

• Vaccination-induced T cell responses maintain polyclonality with high antigen receptor avidity.

  2025cites this paper
• Evolution by innovation as a driving force to improve TCR-T therapies

  2023cites this paper
• Identification and Characterization of T-cell receptors with therapeutic potential showing conserved specificity against all SARS-CoV 2 strains

  2023cites this paper
• Genome‐wide off‐target analyses of CRISPR/Cas9‐mediated T‐cell receptor engineering in primary human T cells

  2022cites this paper
• Protective T-cell receptor identification for orthotopic reprogramming of immunity in refractory virus infections.

  2021cites this paper
• Simultaneous Deletion of Endogenous TCRαβ for TCR Gene Therapy Creates an Improved and Safe Cellular Therapeutic.

  2020cites this paper
• Orthotopic T-Cell Receptor Replacement—An “Enabler” for TCR-Based Therapies

  2020influential citation
• Orthotopic replacement of T-cell receptor α- and β-chains with preservation of near-physiological T-cell function

  2019cites this paper
• Untouched GMP-Ready Purified Engineered Immune Cells to Treat Cancer

  2015cites this paper
• GMP-ready purified engineered immune cells to treat cancer Running title : Purified engineered immune cells

  2015cites this paper
• Genetically modulating T-cell function to target cancer.

  2012cites this paper
• Genetic modification of lymphocytes by retrovirus-based vectors.

  2012cites this paper
• How (specific) would you like your T-cells today? Generating T-cell therapeutic function through TCR-gene transfer

  2012cites this paper